Associate professor, Jiangxi Key Laboratory of oncology, JXHC Key Laboratory of Tumor Metastasis, Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College, Jiangxi Cancer Institute, Nanchang, Jiangxi, 330029, P.R. China, China🧬
Dr. Hazrat Bilal is a distinguished microbiologist specializing in infectious diseases and antimicrobial resistance. With a strong academic foundation and extensive research experience, he has contributed significantly to the understanding of fungal infections and antibiotic resistance. He has received multiple accolades for his academic excellence and research contributions, including gold medals during his M.Phil. and BS studies. Currently, he is serving as a researcher at Jiangxi Cancer Hospital, China, and has held various positions in both academia and the pharmaceutical industry. His groundbreaking work in microbiology has been published in high-impact journals, making valuable contributions to the scientific community.
Profile
Google Scholar
Education 🎓
Dr. Hazrat Bilal has a strong academic background in microbiology, earning prestigious degrees with honors. He obtained his Ph.D. in Ecology (Microbiology specialization) from Anhui University, China (2018–2021). Before that, he completed his M.Phil. in Microbiology from Khyber Medical University, Pakistan (2016–2018), graduating as a Gold Medalist with the highest CGPA of 3.85/4. His BS (Hons) in Microbiology was awarded by Hazara University, Pakistan (2010–2014), where he again graduated with the highest distinction and a CGPA of 3.92/4, securing another Gold Medal for academic excellence.
Professional Experience 🔬
Dr. Bilal is currently working as a researcher at Jiangxi Cancer Hospital, China (March 2024 – Present). Previously, he served as a Postdoctoral Researcher at the Second Affiliated Hospital of SUMC, Shantou, China (March 2022 – March 2024), where he conducted extensive research on infectious diseases. Before transitioning into research, he worked as a Medicinal Sales Officer at Sami Pharmaceutical Company Pvt Ltd, Pakistan (December 2014 – February 2016), gaining industry experience in pharmaceutical sales and drug distribution.
Research Interests 🦠
Dr. Bilal’s research primarily focuses on microbiology, infectious diseases, and antimicrobial resistance. His work includes epidemiological studies, fungal infections, antifungal drug susceptibility, and molecular mechanisms of antibiotic resistance. He has extensively studied Candida and Aspergillus infections, drug resistance patterns, and microbial dysbiosis, contributing significantly to the field of medical microbiology.
Awards & Honors 🏆
Dr. Bilal has received multiple accolades throughout his academic and professional career. He was a Gold Medalist in both his BS (Hons) and M.Phil. degrees, recognizing his outstanding academic performance. Additionally, his research has been recognized internationally, with publications in high-impact journals. His work continues to be cited widely, solidifying his reputation in the field of microbiology and infectious disease research.
Publications 📚
Epidemiology and antifungal susceptibilities of clinically isolated Aspergillus species in South China
Epidemiology and Infection (IF: 4.2, Q2), 2023 | Cited by: Google Scholar
Risk of candidiasis associated with interleukin-17 inhibitors: implications and management
Mycology: An International Journal of Fungal Biology (IF: 4.2, Q1), 2023 | Cited by: Google Scholar
Cryptococcosis in Southern China: Insights from a Six-Year Retrospective Study
Infection and Drug Resistance (IF: 3.9, Q2), 2023 | Cited by: Google Scholar
Six-Year Retrospective Analysis of Epidemiology, Risk Factors, and Antifungal Susceptibilities of Candidiasis
Microbiology Spectrum (IF: 9.043, Q1), 2023 | Cited by: Google Scholar
Stabilization of Acne Vulgaris-Associated Microbial Dysbiosis with 2% Supramolecular Salicylic Acid
Pharmaceuticals (IF: 5.215, Q1), 2023 | Cited by: Google Scholar
Distribution and antifungal susceptibility pattern of Candida species from mainland China
Virulence (IF: 5.428, Q2), 2022 | Cited by: Google Scholar
Antifungal susceptibility pattern of Candida isolated from cutaneous candidiasis patients in Eastern Guangdong
Frontiers in Microbiology (IF: 6.064, Q1), 2022 | Cited by: Google Scholar
First Report of blaNDM-1 Bearing IncX3 Plasmid in Clinically Isolated ST11 Klebsiella pneumoniae from Pakistan
Microorganisms (IF: 4.926, Q2), 2021 | Cited by: Google Scholar
Molecular Epidemiology of mcr-1, blaKPC-2, and blaNDM-1 Harboring Clinically Isolated Escherichia coli from Pakistan
Infection and Drug Resistance (IF: 4.177, Q2), 2021 | Cited by: Google Scholar
Antibiotic resistance in Pakistan: A systematic review of the past decade
BMC Infectious Diseases (IF: 3.669, Q3), 2021 | Cited by: Google Scholar
Conclusion
Dr. Bilal H. is a highly competent researcher with a strong track record in microbiology, infectious diseases, and antimicrobial resistance. His extensive publication record, international research exposure, and academic excellence make him a strong contender for the Best Researcher Award. Further development in leadership, funding acquisition, and industry collaborations would further solidify his standing in the field. 🌟